Special Report
Pharm Exec’s Top 50 Pharma Companies
It’s time for our annual round-up of the world’s top 50 pharma companies: this year, patent expiries dampen revenues for some of the biggest Big Pharma, but growth continues unabated for a few nimble "stealth" players moving steadily up the list ...Read more
CEO Compensation Data
Complete salary, bonus & market capitalization data in biotech.
 www.bioworld.com
Healthcare Reform
Obamacare to Boost Private Managed Healthcare
Over 30 million newly insured patients under the Affordable Care Act (ACA) will receive coverage through the mandated Health Insurance Exchanges or the now-optional Medicaid expansion. Sounds like government expansion, right? Well, not exactly ...Read More
The Waiting Game: Ways to Prepare for the AMP Final Rule
Live Webcast: Tuesday, June 4, 2013 from Noon to 1:00 PM Eastern
Register Free at
 www.pharmexec.com/ampfinal
Washington Report
Generic Drug Gains and Grumbles
All the reports on the rise and fall in drug spending have one common feature: most savings come from increased use of generic drugs. Low-cost copycat medicines now account for more than 80 percent of US prescriptions, the number rising in recent years as more blockbuster therapies have lost patent protection. Jill Wechsler reports ...Read more
Global
FDA Issues Warning to Boehringer Ingelheim for cGMP Violations
FDA has issued a Warning Letter to Boehringer Ingelheim for cGMP violations for the manufacture of APIs and finished pharmaceuticals at its facility in Ingelheim am Rhein, Germany. The letter, issued on May 6, 2013, was based on an inspection of the facility Nov. 5–12, 2012 and subsequent response by the company based on that inspection in which FDA cited insufficient corrective actions ...Read more
Global
Read the New Pharm Exec Global Digest — Patents Special
In May’s issue: India’s Glivec Ruling — the Aftermath; Europe’s Unitary Patent — cause for excitement?; the UK Patent Box — will it hold delights for the industry? Also: a new era for UK’s NICE; smarter multichannel marketing; and more ...Read more
|
